Which has stronger valuation & earnings, ALGN or DVA?

DaVita has higher revenue and earnings than Align Technology. DaVita is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Align Technology $4.03B 2.68 $410.35M $5.75 26.21 DaVita $13.64B 0.85 $746.80M $12.22 14.84

Is ALGN or DVA more profitable?

Align Technology has a net margin of 9.99% compared to DaVita's net margin of 6.05%. Align Technology's return on equity of 15.86% beat DaVita's return on equity. Company Net Margins Return on Equity Return on Assets Align Technology 9.99% 15.86% 10.32% DaVita 6.05% -217.63% 5.07%

Does the media refer more to ALGN or DVA?

In the previous week, Align Technology had 1 more articles in the media than DaVita. MarketBeat recorded 9 mentions for Align Technology and 8 mentions for DaVita. Align Technology's average media sentiment score of 1.13 beat DaVita's score of 0.88 indicating that Align Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DaVita 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, DVA or DXCM?

DexCom has lower revenue, but higher earnings than DaVita. DaVita is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DaVita $13.64B 0.85 $746.80M $12.22 14.84 DexCom $4.66B 6.84 $836.30M $2.53 33.40

Is DVA or DXCM more profitable?

DexCom has a net margin of 20.12% compared to DaVita's net margin of 6.05%. DexCom's return on equity of 35.94% beat DaVita's return on equity. Company Net Margins Return on Equity Return on Assets DaVita 6.05% -217.63% 5.07% DexCom 20.12% 35.94% 14.75%

Does the media prefer DVA or DXCM?

In the previous week, DexCom had 7 more articles in the media than DaVita. MarketBeat recorded 15 mentions for DexCom and 8 mentions for DaVita. DexCom's average media sentiment score of 0.93 beat DaVita's score of 0.88 indicating that DexCom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DaVita 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 7 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, HQY or DVA?

DaVita has higher revenue and earnings than HealthEquity. DaVita is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HealthEquity $1.31B 5.95 $215.20M $2.77 34.13 DaVita $13.64B 0.85 $746.80M $12.22 14.84

Is HQY or DVA more profitable?

HealthEquity has a net margin of 17.36% compared to DaVita's net margin of 6.05%. HealthEquity's return on equity of 15.33% beat DaVita's return on equity. Company Net Margins Return on Equity Return on Assets HealthEquity 17.36% 15.33% 9.51% DaVita 6.05% -217.63% 5.07%

Does the media refer more to HQY or DVA?

In the previous week, DaVita had 3 more articles in the media than HealthEquity. MarketBeat recorded 8 mentions for DaVita and 5 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.90 beat DaVita's score of 0.88 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DaVita 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, DVA or MMSI?

DaVita has higher revenue and earnings than Merit Medical Systems. DaVita is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DaVita $13.64B 0.85 $746.80M $12.22 14.84 Merit Medical Systems $1.52B 3.41 $128.49M $2.42 35.73

Does the media favor DVA or MMSI?

In the previous week, DaVita had 2 more articles in the media than Merit Medical Systems. MarketBeat recorded 8 mentions for DaVita and 6 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.56 beat DaVita's score of 0.88 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DaVita 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has better valuation & earnings, CAH or DVA?

Cardinal Health has higher revenue and earnings than DaVita. DaVita is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cardinal Health $254.25B 0.22 $1.71B $7.23 32.64 DaVita $13.64B 0.85 $746.80M $12.22 14.84

Does the media refer more to CAH or DVA?

In the previous week, Cardinal Health had 5 more articles in the media than DaVita. MarketBeat recorded 13 mentions for Cardinal Health and 8 mentions for DaVita. Cardinal Health's average media sentiment score of 1.14 beat DaVita's score of 0.88 indicating that Cardinal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cardinal Health 10 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DaVita 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

DaVita (DVA) Competitors

$181.36 -1.65 (-0.90%)

Closing price 03:59 PM Eastern

Extended Trading

$182.00 +0.64 (+0.35%)

As of 07:46 PM Eastern

Compare

DVA vs. ALGN, DXCM, HQY, MMSI, and CAH

Should you buy DaVita stock or one of its competitors? DaVita's main competitors and comparable companies include Align Technology (ALGN), DexCom (DXCM), HealthEquity (HQY), Merit Medical Systems (MMSI), and Cardinal Health (CAH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does DaVita compare to Align Technology?

Align Technology (NASDAQ:ALGN) and DaVita (NYSE:DVA) are both large-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership and valuation.

In the previous week, Align Technology had 1 more articles in the media than DaVita. MarketBeat recorded 9 mentions for Align Technology and 8 mentions for DaVita. Align Technology's average media sentiment score of 1.13 beat DaVita's score of 0.88 indicating that Align Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Align Technology	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DaVita	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

DaVita has higher revenue and earnings than Align Technology. DaVita is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$4.03B	2.68	$410.35M	$5.75	26.21
DaVita	$13.64B	0.85	$746.80M	$12.22	14.84

Align Technology presently has a consensus target price of $206.36, indicating a potential upside of 36.91%. DaVita has a consensus target price of $233.43, indicating a potential upside of 28.71%. Given Align Technology's stronger consensus rating and higher possible upside, research analysts plainly believe Align Technology is more favorable than DaVita.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67
DaVita	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57

88.4% of Align Technology shares are held by institutional investors. Comparatively, 90.1% of DaVita shares are held by institutional investors. 0.8% of Align Technology shares are held by insiders. Comparatively, 1.9% of DaVita shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Align Technology has a net margin of 9.99% compared to DaVita's net margin of 6.05%. Align Technology's return on equity of 15.86% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	9.99%	15.86%	10.32%
DaVita	6.05%	-217.63%	5.07%

Align Technology has a beta of 1.65, indicating that its share price is 65% more volatile than the broader market. Comparatively, DaVita has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market.

Summary

Align Technology beats DaVita on 12 of the 17 factors compared between the two stocks.

How does DaVita compare to DexCom?

DaVita (NYSE:DVA) and DexCom (NASDAQ:DXCM) are both large-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

DaVita has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market. Comparatively, DexCom has a beta of 1.42, indicating that its share price is 42% more volatile than the broader market.

In the previous week, DexCom had 7 more articles in the media than DaVita. MarketBeat recorded 15 mentions for DexCom and 8 mentions for DaVita. DexCom's average media sentiment score of 0.93 beat DaVita's score of 0.88 indicating that DexCom is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DaVita	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DexCom	7 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

90.1% of DaVita shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 1.9% of DaVita shares are held by insiders. Comparatively, 0.3% of DexCom shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

DexCom has a net margin of 20.12% compared to DaVita's net margin of 6.05%. DexCom's return on equity of 35.94% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DaVita	6.05%	-217.63%	5.07%
DexCom	20.12%	35.94%	14.75%

DexCom has lower revenue, but higher earnings than DaVita. DaVita is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DaVita	$13.64B	0.85	$746.80M	$12.22	14.84
DexCom	$4.66B	6.84	$836.30M	$2.53	33.40

DaVita presently has a consensus price target of $233.43, indicating a potential upside of 28.71%. DexCom has a consensus price target of $88.71, indicating a potential upside of 4.97%. Given DaVita's higher probable upside, research analysts plainly believe DaVita is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DaVita	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57
DexCom	1 Sell rating(s)	2 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.92

Summary

DexCom beats DaVita on 13 of the 17 factors compared between the two stocks.

How does DaVita compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and DaVita (NYSE:DVA) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

In the previous week, DaVita had 3 more articles in the media than HealthEquity. MarketBeat recorded 8 mentions for DaVita and 5 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.90 beat DaVita's score of 0.88 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DaVita	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market. Comparatively, DaVita has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market.

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 90.1% of DaVita shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by insiders. Comparatively, 1.9% of DaVita shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

HealthEquity has a net margin of 17.36% compared to DaVita's net margin of 6.05%. HealthEquity's return on equity of 15.33% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.36%	15.33%	9.51%
DaVita	6.05%	-217.63%	5.07%

DaVita has higher revenue and earnings than HealthEquity. DaVita is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	5.95	$215.20M	$2.77	34.13
DaVita	$13.64B	0.85	$746.80M	$12.22	14.84

HealthEquity presently has a consensus target price of $111.87, indicating a potential upside of 18.31%. DaVita has a consensus target price of $233.43, indicating a potential upside of 28.71%. Given DaVita's higher possible upside, analysts plainly believe DaVita is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.85
DaVita	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57

Summary

HealthEquity beats DaVita on 10 of the 17 factors compared between the two stocks.

How does DaVita compare to Merit Medical Systems?

DaVita (NYSE:DVA) and Merit Medical Systems (NASDAQ:MMSI) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment and earnings.

DaVita currently has a consensus target price of $233.43, indicating a potential upside of 28.71%. Merit Medical Systems has a consensus target price of $100.00, indicating a potential upside of 15.65%. Given DaVita's higher probable upside, equities analysts plainly believe DaVita is more favorable than Merit Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DaVita	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57
Merit Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83

90.1% of DaVita shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 1.9% of DaVita shares are held by insiders. Comparatively, 0.7% of Merit Medical Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, DaVita had 2 more articles in the media than Merit Medical Systems. MarketBeat recorded 8 mentions for DaVita and 6 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.56 beat DaVita's score of 0.88 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DaVita	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

DaVita has higher revenue and earnings than Merit Medical Systems. DaVita is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DaVita	$13.64B	0.85	$746.80M	$12.22	14.84
Merit Medical Systems	$1.52B	3.41	$128.49M	$2.42	35.73

DaVita has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.49, suggesting that its share price is 51% less volatile than the broader market.

Merit Medical Systems has a net margin of 9.22% compared to DaVita's net margin of 6.05%. Merit Medical Systems' return on equity of 13.75% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DaVita	6.05%	-217.63%	5.07%
Merit Medical Systems	9.22%	13.75%	8.10%

Summary

Merit Medical Systems beats DaVita on 10 of the 17 factors compared between the two stocks.

How does DaVita compare to Cardinal Health?

Cardinal Health (NYSE:CAH) and DaVita (NYSE:DVA) are both large-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, media sentiment, earnings, dividends and profitability.

Cardinal Health has a beta of 0.51, indicating that its share price is 49% less volatile than the broader market. Comparatively, DaVita has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market.

DaVita has a net margin of 6.05% compared to Cardinal Health's net margin of 0.67%. Cardinal Health's return on equity of -98.53% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardinal Health	0.67%	-98.53%	4.69%
DaVita	6.05%	-217.63%	5.07%

Cardinal Health presently has a consensus target price of $266.56, suggesting a potential upside of 12.97%. DaVita has a consensus target price of $233.43, suggesting a potential upside of 28.71%. Given DaVita's higher probable upside, analysts clearly believe DaVita is more favorable than Cardinal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardinal Health	0 Sell rating(s)	3 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.84
DaVita	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57

Cardinal Health has higher revenue and earnings than DaVita. DaVita is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardinal Health	$254.25B	0.22	$1.71B	$7.23	32.64
DaVita	$13.64B	0.85	$746.80M	$12.22	14.84

87.2% of Cardinal Health shares are held by institutional investors. Comparatively, 90.1% of DaVita shares are held by institutional investors. 0.1% of Cardinal Health shares are held by insiders. Comparatively, 1.9% of DaVita shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Cardinal Health had 5 more articles in the media than DaVita. MarketBeat recorded 13 mentions for Cardinal Health and 8 mentions for DaVita. Cardinal Health's average media sentiment score of 1.14 beat DaVita's score of 0.88 indicating that Cardinal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cardinal Health	10 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DaVita	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cardinal Health and DaVita tied by winning 8 of the 16 factors compared between the two stocks.

Get DaVita News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DVA vs. The Competition

Export

Metric	DaVita	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$11.68B	$9.90B	$7.21B	$23.36B
Dividend Yield	N/A	2.60%	2.56%	3.78%
P/E Ratio	14.84	28.39	213.24	24.60
Price / Sales	0.85	5.03	618.41	20.61
Price / Cash	8.43	125.92	77.33	34.40
Price / Book	-34.28	5.29	10.43	4.70
Net Income	$746.80M	$313.25M	$3.49B	$1.07B
7 Day Performance	-0.35%	-1.39%	-2.99%	-2.33%
1 Month Performance	-1.12%	-1.89%	0.02%	-2.85%
1 Year Performance	37.09%	15.18%	20.19%	10.59%

DaVita Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DVA DaVita	4.6348 of 5 stars	$181.36 -0.9%	$233.43 +28.7%	+33.9%	$11.68B	$13.64B	14.84	78,000
ALGN Align Technology	3.9008 of 5 stars	$159.79 +1.4%	$206.36 +29.1%	+12.5%	$11.29B	$4.03B	27.79	20,290	Positive News Options Volume
DXCM DexCom	3.4833 of 5 stars	$91.06 +0.3%	$88.71 -2.6%	+7.0%	$34.27B	$4.66B	35.99	11,000
HQY HealthEquity	4.2739 of 5 stars	$96.54 +0.2%	$111.87 +15.9%	-0.4%	$7.97B	$1.31B	34.85	2,814
MMSI Merit Medical Systems	3.9152 of 5 stars	$90.66 +0.2%	$100.00 +10.3%	-4.9%	$5.40B	$1.52B	37.46	7,500	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:DVA) was last updated on 9/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DaVita (DVA) Competitors

DVA vs. ALGN, DXCM, HQY, MMSI, and CAH

How does DaVita compare to Align Technology?

Summary

How does DaVita compare to DexCom?

Summary

How does DaVita compare to HealthEquity?

Summary

How does DaVita compare to Merit Medical Systems?

Summary

How does DaVita compare to Cardinal Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DVA vs. The Competition

DaVita Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DaVita (DVA) Competitors

DVA vs. ALGN, DXCM, HQY, MMSI, and CAH

How does DaVita compare to Align Technology?

Does the media refer more to ALGN or DVA?

Which has stronger valuation & earnings, ALGN or DVA?

Do analysts recommend ALGN or DVA?

Do insiders and institutionals believe in ALGN or DVA?

Is ALGN or DVA more profitable?

Which has more risk and volatility, ALGN or DVA?

Summary

How does DaVita compare to DexCom?

Which has more volatility & risk, DVA or DXCM?

Does the media prefer DVA or DXCM?

Do institutionals and insiders have more ownership in DVA or DXCM?

Is DVA or DXCM more profitable?

Which has stronger earnings & valuation, DVA or DXCM?

Do analysts prefer DVA or DXCM?

Summary

How does DaVita compare to HealthEquity?

Does the media refer more to HQY or DVA?

Which has more risk and volatility, HQY or DVA?

Do insiders and institutionals hold more shares of HQY or DVA?

Is HQY or DVA more profitable?

Which has higher valuation & earnings, HQY or DVA?

Do analysts prefer HQY or DVA?

Summary

How does DaVita compare to Merit Medical Systems?

Do analysts prefer DVA or MMSI?

Do institutionals and insiders have more ownership in DVA or MMSI?

Does the media favor DVA or MMSI?

Which has preferable valuation and earnings, DVA or MMSI?

Which has more volatility & risk, DVA or MMSI?

Is DVA or MMSI more profitable?

Summary

How does DaVita compare to Cardinal Health?

Which has more volatility & risk, CAH or DVA?

Is CAH or DVA more profitable?

Do analysts recommend CAH or DVA?

Which has better valuation & earnings, CAH or DVA?

Do insiders & institutionals believe in CAH or DVA?

Does the media refer more to CAH or DVA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DVA vs. The Competition

DaVita Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools